Heterodimeric antibodies to CD3 X CD123

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856327
APP PUB NO 20170081424A1
SERIAL NO

15186167

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel heterodimeric antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • XENCOR, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernett, Matthew J Monrovia, US 82 1810
Chu, Seung Cypress, US 33 741
Desjarlais, John Pasadena, US 142 2835
Lee, Sung-Hyung San Gabriel, US 26 239
Moore, Gregory Azusa, US 115 2099
Muchhal, Umesh Monrovia, US 32 403
Rashid, Rumana Temple City, US 75 1525

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00